Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|September 11, 2012
LSD1 inhibition: a therapeutic strategy in cancer?James T Lynch, William J Harris, Tim C P Somervaille
Archives of Pathology & Laboratory Medicine|May 30, 2002
Natural killer-like T-cell lymphoma of the parotid in a patient infected with human immunodeficiency virusDennis B Cornfield, Joseph S Papiez, James T Lynch, et al.
Molecular & Cellular Oncology|September 26, 2018
LSD1 inhibitors disrupt the GFI1 transcription repressor complexAlba Maiques-Diaz, James T Lynch, Gary J Spencer, et al.
Molecular Cancer|February 17, 2010
The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expressionJames T Lynch, Ramkumar Rajendran, Georgia Xenaki, et al.
Pharmacogenomics|December 3, 2010
Quantitative analysis and modeling of glucocorticoid-controlled gene expressionDaphne Wei-Chen Chen, James T Lynch, Constantinos Demonacos, et al.
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Molecular Endocrinology (Baltimore, Md.)|March 14, 2008
Cross talk of signaling pathways in the regulation of the glucocorticoid receptor functionLaura Davies, Nirupama Karthikeyan, James T Lynch, et al.
Cancer Cell|September 17, 2015
Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid LeukemiaTim D D Somerville, Daniel H Wiseman, Gary J Spencer, et al.
Pageof 3